<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>EAPSI:  Development of a three-dimensional microfluidic platform for liver cancer cell angiogenesis system</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>06/01/2010</AwardEffectiveDate>
<AwardExpirationDate>05/31/2011</AwardExpirationDate>
<AwardTotalIntnAmount>5617.00</AwardTotalIntnAmount>
<AwardAmount>5617</AwardAmount>
<AwardInstrument>
<Value>Fellowship Award</Value>
</AwardInstrument>
<Organization>
<Code>01090000</Code>
<Directorate>
<Abbreviation>O/D</Abbreviation>
<LongName>Office Of The Director</LongName>
</Directorate>
<Division>
<Abbreviation>OISE</Abbreviation>
<LongName>Office Of Internatl Science &amp;Engineering</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anne Emig</SignBlockName>
<PO_EMAI>aemig@nsf.gov</PO_EMAI>
<PO_PHON>7032927241</PO_PHON>
</ProgramOfficer>
<AbstractNarration/>
<MinAmdLetterDate>06/04/2010</MinAmdLetterDate>
<MaxAmdLetterDate>06/04/2010</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.079</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1014704</AwardID>
<Investigator>
<FirstName>Jessie</FirstName>
<LastName>Jeon</LastName>
<PI_MID_INIT>S</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Jessie S Jeon</PI_FULL_NAME>
<EmailAddress/>
<PI_PHON>6174291065</PI_PHON>
<NSF_ID>000546374</NSF_ID>
<StartDate>06/04/2010</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Jeon                    Jessie         S</Name>
<CityName>Cambridge</CityName>
<ZipCode>021394204</ZipCode>
<PhoneNumber/>
<StreetAddress/>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Massachusetts</StateName>
<StateCode>MA</StateCode>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>MA07</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM/>
<ORG_LGL_BUS_NAME/>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Jeon                    Jessie         S]]></Name>
<CityName>Cambridge</CityName>
<StateCode>MA</StateCode>
<ZipCode>021394204</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Massachusetts</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>MA07</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramElement>
<ProgramReference>
<Code>5942</Code>
<Text>KOREA</Text>
</ProgramReference>
<ProgramReference>
<Code>5978</Code>
<Text>EAST ASIA AND PACIFIC PROGRAM</Text>
</ProgramReference>
<ProgramReference>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramReference>
<Appropriation>
<Code>0110</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2010~5617</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>The microfluidic chips serve as a facile tool to monitor cell behaviors. Over the course of this project I have participated both in fabrication part of the microfluidic platform using new material and the cell culture work with previously developed microfludic system.</p> <p>For microfluidic chip fabrication, we have collaborated together with a goal of manufacturing the chip using injection molding. I have previously manufactured the chip by hot embossing and thermal bonding, but this new collaboration led to a possibility in commercial use, since injection molding enables mass manufacturing of the devices unlike hot embossing.The injection molding is currently being done at a facility located at the outskirts of Seoul. We will be using two different materials for injection molding, acryl and cyclic olefin copolymer (COC), and compare the quality and manufacturability of the devices once we obtain 500 devices for each material. The next step after injection molding is bonding the patterned polymer with thin film, completing the device fabrication. For the bonding step, we planned to use the exact same technique that I have developed for the hot embossed devices. The optimization for thermal bonding of film to the devices is still undergoing for the equipments in Korea. I will take the devices fabricated through injection molding and use them to test hydrogel injection into those devices and cell culture afterwards. &nbsp;</p> <p>The other aspect of the project during my tenure of EAPSI program included the cell culture work using polydimethylsiloxane (PDMS) devices. In PDMS devices, I have cultured vascular cells breast cancer cells. With Korean graduate students who are working on each of those cells, I have introduced those cells in the devices separately. The aim of vascular cell experiments was to provide a complete one uniform layer of cells that is covering the entire gel region without any sprouting of cells into the gel. This was done by varying the density as well as the stiffness of the gel so that the cells could not penetrate into the gel. The complete monolayer mimics the lining of human dermal endothelial cells, and introduction of migrating cells into the device with monolayer can be useful in observing the crossing of endothelial cell behavior. The experiment was particularly helpful for research undergoing at both institutions since the students at Korea University needed a monolayer for co-culture with human neutrophil transendothelial work while I wanted the monolayer for co-culture with breast cancer cell extravasation through the endothelial cell. This is where cancer cell culture work with the other student at Korea University comes in useful. The experiment consists of blocking specific receptors and attracting the cells through chemokines to induce more or less migration of cancer cells in the hydrogel scaffold. I have acquired more knowledge about the cancer cell through the collaboration, especially about the cell receptors that are known to influence migration.&nbsp;</p><br> <p>            Last Modified: 06/01/2011<br>      Modified by: Jessie&nbsp;S&nbsp;Jeon</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ The microfluidic chips serve as a facile tool to monitor cell behaviors. Over the course of this project I have participated both in fabrication part of the microfluidic platform using new material and the cell culture work with previously developed microfludic system.  For microfluidic chip fabrication, we have collaborated together with a goal of manufacturing the chip using injection molding. I have previously manufactured the chip by hot embossing and thermal bonding, but this new collaboration led to a possibility in commercial use, since injection molding enables mass manufacturing of the devices unlike hot embossing.The injection molding is currently being done at a facility located at the outskirts of Seoul. We will be using two different materials for injection molding, acryl and cyclic olefin copolymer (COC), and compare the quality and manufacturability of the devices once we obtain 500 devices for each material. The next step after injection molding is bonding the patterned polymer with thin film, completing the device fabrication. For the bonding step, we planned to use the exact same technique that I have developed for the hot embossed devices. The optimization for thermal bonding of film to the devices is still undergoing for the equipments in Korea. I will take the devices fabricated through injection molding and use them to test hydrogel injection into those devices and cell culture afterwards.    The other aspect of the project during my tenure of EAPSI program included the cell culture work using polydimethylsiloxane (PDMS) devices. In PDMS devices, I have cultured vascular cells breast cancer cells. With Korean graduate students who are working on each of those cells, I have introduced those cells in the devices separately. The aim of vascular cell experiments was to provide a complete one uniform layer of cells that is covering the entire gel region without any sprouting of cells into the gel. This was done by varying the density as well as the stiffness of the gel so that the cells could not penetrate into the gel. The complete monolayer mimics the lining of human dermal endothelial cells, and introduction of migrating cells into the device with monolayer can be useful in observing the crossing of endothelial cell behavior. The experiment was particularly helpful for research undergoing at both institutions since the students at Korea University needed a monolayer for co-culture with human neutrophil transendothelial work while I wanted the monolayer for co-culture with breast cancer cell extravasation through the endothelial cell. This is where cancer cell culture work with the other student at Korea University comes in useful. The experiment consists of blocking specific receptors and attracting the cells through chemokines to induce more or less migration of cancer cells in the hydrogel scaffold. I have acquired more knowledge about the cancer cell through the collaboration, especially about the cell receptors that are known to influence migration.        Last Modified: 06/01/2011       Submitted by: Jessie S Jeon]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
